TUMOR CAVITATION IN PATIENTS WITH STAGE III NON-SMALL-CELL LUNG CANCER UNDERGOING CONCURRENT CHEMORADIOTHERAPY: INCIDENCE AND OUTCOMES

被引：0
|
作者：
Phernambucq, Erik C. [1 ]
Hartemink, Koen J. [2 ]
Smit, Egbert F. [1 ]
Paul, M. A. [2 ]
Postmus, Pieter E. [1 ]
Senan, Suresh [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Thorac Surg, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
concurrent chemoradiotherapy; tumor cavitation; stage III NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S633 / S633
页数：1
相关论文
共 50 条
  • [31] Determinants of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients
    Walraven, Iris
    Ten Berge, M.
    Damhuis, Ronald
    Tissing-Tan, C.
    Troost, E.
    Reymen, B.
    Widder, J.
    Koppe, F.
    Van Der Wel, A.
    Vonk, E.
    Coremans, I.
    Bussink, J.
    De Jaeger, K.
    Van Zyp, N. Van Der Voort
    El Sharouni, Sherif
    Knol, H.
    Woutersen, D.
    Belderbos, Jose
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S539 - S539
  • [32] Concurrent radiochemotherapy with ifosfamide in unresectable stage III non-small-cell lung cancer
    Schraube, P
    Latz, D
    Manegold, C
    Bischoff, H
    Krempien, R
    Pressler, K
    Wannenmacher, M
    Drings, P
    ONKOLOGIE, 1998, 21 (01): : 57 - 62
  • [33] Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer
    Naito, Yoichi
    Kubota, Kaoru
    Nihei, Keiji
    Fujii, Tomonori
    Yoh, Kiyotaka
    Niho, Seiji
    Goto, Koichi
    Ohmatsu, Hironobu
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : 617 - 622
  • [34] Clinical Outcomes of Concurrent Chemoradiotherapy Versus Radiotherapy Alone in the Elderly Patients with Stage III Non-Small Cell Lung Cancer
    Kim, D. Y.
    Song, C.
    Kim, S. H.
    Kim, Y. J.
    Lee, J. S.
    Kim, J. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E514 - E514
  • [35] Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer
    Kang S.-R.
    Song H.-C.
    Byun B.H.
    Oh J.-R.
    Kim H.-S.
    Hong S.-P.
    Kwon S.Y.
    Chong A.
    Kim J.
    Cho S.-G.
    Park H.J.
    Kim Y.-C.
    Ahn S.-J.
    Min J.-J.
    Bom H.-S.
    Nuclear Medicine and Molecular Imaging, 2014, 48 (1) : 16 - 25
  • [36] Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer
    Horinouchi, Hidehito
    Sekine, Ikuo
    Sumi, Minako
    Noda, Kazumasa
    Goto, Koichi
    Mori, Kiyoshi
    Tamura, Tomohide
    CANCER SCIENCE, 2013, 104 (01) : 93 - 97
  • [37] Concurrent Chemoradiotherapy for Patients With Postoperative Recurrence of Surgically Resected Non-Small-Cell Lung Cancer
    Takenaka, Tomoyoshi
    Takenoyama, Mitsuhiro
    Toyozawa, Ryo
    Inamasu, Eiko
    Yoshida, Tsukihisa
    Toyokawa, Gouji
    Shiraishi, Yoshimasa
    Hirai, Fumihiko
    Yamaguchi, Masafumi
    Seto, Takashi
    Ichinose, Yukito
    CLINICAL LUNG CANCER, 2015, 16 (01) : 51 - 56
  • [38] EFFICACY OF CONCURRENT CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER
    Almodovar, M.
    Ramos, H.
    Mota, P.
    Martins, V.
    Pereira, P.
    LUNG CANCER, 2011, 71 : S42 - S43
  • [39] Early tumor shrinkage served as a prognostic factor for patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy
    Wei, Min
    Ye, Qingqing
    Wang, Xuan
    Wang, Men
    Hu, Yan
    Yang, Yonghua
    Yang, Jiyuan
    Cai, Jun
    MEDICINE, 2018, 97 (19)
  • [40] Early recurrence factors in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy
    Takahara, Yutaka
    Tanaka, Takuya
    Ishige, Yoko
    Shionoya, Ikuyo
    Yamamura, Kouichi
    Sakuma, Takashi
    Nishiki, Kazuaki
    Nakase, Keisuke
    Nojiri, Masafumi
    Kato, Ryo
    Shinomiya, Shohei
    Oikawa, Taku
    Mizuno, Shiro
    THORACIC CANCER, 2022, 13 (24) : 3451 - 3458
12345